Corporate Profile
Seattle-based Atossa Therapeutics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.
Latest Quarterly Earnings
News Releases
Events
Nov 4, 2024 5:00 PM CET
Oct 16, 2024 12:00 PM EDT
Sep 9, 2024 7:00 AM EDT
Annual Reports
Investor Relations Contact
Michael Parks
VP, Investor and Public Relations
michael.parks@atossainc.com
